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Abstract – A number of bacteria, virus and other 
unhealthy cells need to be killed for getting rid of them. 
For more than a century antibiotics have been effectively 
used for killing bacterial pathogens and chemical drugs 
against the cancer cells.   However, there are bacteria 
and cancer cells that are drug resistant. This may have to 
be overcome by other stronger drugs, higher dosage. 
These can have detrimental side effects. Other non drug 
methods to aid the   effect of these drugs have always 
been in research. Electrochemotherapy, a   method of 
using electric fields along with the drug to be used 
topically has been one of the successful approaches. One 
of the most recent methods of Tumor Treating 
Frequencies (TTF) for a brain cancer has been FDA 
approved. This article details the use of TTF . The article 
also details some other latest research where alternating 
fields are used as antibacterial agents.  
 
Index Terms – alternating electric field, biomedical 
applications. 
  
INTRODUCTION 
The 20th century was the modern era full of invention 
of antibacterial agents.  Millions of people have been 
cured due to the treatment with the numerous antibiotic 
drugs used today. In the 21st century these antibacterial 
drugs surely play an important role in the battle against 
the ever increasing variety of bacteria. However, the 
extensive use of antibiotics holds a threat in the future 
due to the rapid rise of multi drug resistant bacteria. 
Recently, a number of alternative modes like weak 
electric currents [1,2,3,4],  ultrasound wave therapy 
[5,6,7] , thermotherapy [8],  photodynamic therapy [9]  
have been studied. These are expected to aid the 
antibiotics in the battle against bacterial pathogens. 
They definitely have an advantage of being non-drug 
based. However, the main drawback of the above 
mentioned methods is the high level of heating 
produced by the ultrasound waves and thermography 
[10]. In addition, the activated oxygen produced by the 
use of photodynamic therapy, both of which can 
damage the tissues in and surrounding the target area 
(11). 
  
  In addition, electric currents which are generated by 
the use of conductive electrodes are associated with the 
release of metal ions and free radicals at the electrode 
surface. These are well known to be toxic to living 
cells (12).  As of today, none of the above-mentioned 
has been approved to be a method of treatment against 
bacterial control. However researchers have now 
shown that low intensity alternating fields of high 
frequencies have an in vitro inhibitory effect on growth 
of pathogenic bacteria. 
 
 
USE OF ALTERNATING FIELDS: BACKGROUND 
 
Alternating electric fields have been used since many 
years for the diagnosis, research and treatment of 
various medical conditions.  The properties and effect 
of such electric fields differ, depending on their 
frequency and intensity. Very low frequencies (lower 
than 1 kHz) are capable of exciting the membrane of 
muscles and nerves, thus leading to membrane 
depolarization which leads to action potentials [13-15]. 
These have applications like fracture healing 
Defibrillators and bone growth. 
Higher frequency alternating electric fields penetrate 
cells better, but the overall effect of hyper-
depolarization on the cell membrane counteracts with 
polarization in a way that the integrated stimulation 
does not yield an action potential. However, at 
frequencies higher than 10 MHz,   process of dielectric 
polarization eventually heats the tissue [16,17].  
These find use in Diathermy and radio frequency 
tumor ablation. Intermediate-frequency alternating 
electric fields, at frequencies between 10 kHz and 1 
MHz, neither cause effective depolarization nor 
significant dielectric losses. Thus, these intermediate 
frequencies cannot stimulate muscles ad nerves, but 
also cannot seriously heat tissues at low enough 
intensities. Electric fields at these frequencies were 
considered to have no useful biological effect on cells 
[16, 18] until recent times when researchers have 
mentioned that these ac fields can be used more 
effectively in electroporation based biological 
applications  [19,20].  These fields tend to be of higher 
intensity which can depend on the radius of the cell 
under investigation. Recently  it has been  found that 
such intermediate electric fields, have an effect that 
may lead to the death of dividing cells and thus named 
it as tumor treating fields (TTFields) [21,22]. 
The fields were found to have these properties already 
at a very low intensity (< 2 V/cm) and at intermediate 
frequency of 100 -- 300 kHz [21,22]. 
 
 
FACTS ABOUT TUMOUR TREATING FIELDS: 
 
(a)  TTFields’s mechanism of action 
 
Each cell contains numerous electrically charged 
molecules, such as proteins and DNA. When an 
alternating electric field is applied, these molecules 
will oscillate according to the changing direction of the 
field and its density.   A uniform field will cause a 
movement parallel to the direction of the field. When 
the frequency of the field is high enough, such as in the 
case of TTFields, this molecular movement will 
reduce.   Within a non-dividing cell, the field is mostly 
uniform and the net force on charges and dipoles will, 
therefore, yield minimal movement. Non-uniform 
electric fields cause electrophoresis forcing polar 
molecules to move toward higher field intensity [23, 
24]. These high fields are at the furrow of a dividing 
cell called formed during mitosis. Such fields are 
characteristic of dividing cell when a narrow furrow 
connects the two forming daughter cells. Thus the 
electrical forces acting on the dividing cells affects in a 
way that mitosis becomes arrested for an abnormally 
long time [21]. It is reported that modelling results 
have shown that polarized molecules and organelles 
within the cell   move toward the furrow due to the 
high dielectric force and disrupting the internal cell 
structure and cause the cell destruction [21]. 
 
 
 (b)   Other facts about Tumour Treating Frequency 
fields.  
  
1. TTFields are generated by means electrically    
insulated    ceramic electrodes, thus ensuring 
that no toxic ions are formed as there is no 
electrolysis [22] and can be effectively applied 
using surface electrodes [22]. 
 
2. TTFields can be  delivered via a portable, 
light-weight (~ 3 kg) device carried by the 
patient (NovoTTFields-100A, NovoCure Ltd, 
Haifa, Israel), connected to two pairs of 
insulated electrodes that can be applied to the 
patients’ skin [21,22].  
3.  The device continuously (18 h/day on 
average) delivers two perpendicular 1-2 V/cm, 
200 kHz alternating electric fields [21,22]. 
4.  The only treatment-related adverse event was 
mild-to-moderate contact dermatitis beneath 
the electrode gel, which was easily managed 
using topical treatments [21,22]. 
5. TTFields was shown to inhibit proliferation 
and to cause cell destruction of many cancer 
cells in vitro and in vivo [21,22]. 
6.  There are no serious adverse events found 
related to TTFields as until now [21,22]. 
7. Importantly, there were no cardiac or 
neurological abnormalities as a result of 
TTFields treatment [21,22]. 
8. Due to  non-invasive surface electrodes  flow 
of ionic currents [25] or cell death [26]  is 
prevented as compared to cell death as a result 
of direct currents, and thus     continuous 
treatment is possible. 
9. TTFields can actively inhibit different cell 
types, including multi-drug-resistant [21,22]. 
10. TTFields does not need to be used along with 
any other therapy [21,22]. 
11. Even though TTFields is a regional treatment, 
it still managed to decrease the likelihood of 
metastases formation in animal experiments 
[22]. 
       
TABLE I [27] 
OPTIMAL FREQUNCY FOR DIFFERENT CELL LINES 
 Cell Line Optimal Frequency 
in kHz 
 
 
 B16F1 (mouse melanoma)         120 
AA8 (Chinese hamster ovary)     150 
VX-2 (rabbit kidney)                     150 
MCF-7 (human breast)                150 
MDA-MB-231 (human breast)     150 
F-98 (rat glioma)                          200 
U-87 (Human glioma)                  200 
U-118 (Human glioma)                200 
  
 
  
 
 
 FUTURE OF TTFIELDS 
This use of TTFields is one of the most recent 
researched non invasive, non drug method which is 
capable of inhibiting several cell types including multi 
drug resistant cell lines. Each cell line will be inhibited 
at an optimum frequency specific for the cell line [27] 
as shown in Table 1.With more research the treatment 
can be developed for further applications as follows: 
 
1. There are also some data indicating that combining 
chemotherapeutic cancer treatments with TTFields 
may increase efficacy and sensitivity to 
chemotherapy [28]. 
2. TTFields is a regional treatment: it could be 
employed in situations where radiotherapy is not 
possible [27]. 
3. Even though TTFields is a regional treatment, it 
still manage to decrease the likelihood of 
metastases formation in animal experiments [29]. 
  
  
ANTIBACTERIAL EFFECTS IF ALTERNATING 
FIELDS: 
 
Recent studies using alternating fields using insulated 
electrodes have reported to be useful [30]. Following 
are some facts about the use of antimicrobial fields 
(AMfields). 
1. AMFields  applied using noninvasive, 
insulated electrodes, have a significant 
inhibitory effect on the growth of a pulmonary 
bacterial infection in mice [31]. 
2. The inhibitory effect was observed when 
AMFields were applied either as a 
monotherapy or as an aid to antibiotic therapy 
[31]. 
3. Inhibition of bacterial growth is dependent on 
frequency   of AMFields.ranging from 
100KHz to 10 MHz  with different bacteria 
being sensitive to a specific frequency [31]. 
4.  The antibacterial effect is also field intensity 
dependent with a 30% reduction reported  at 
about  4 V/cm [30] for S. aureus (strain 
SH1000). 
5.  The relatively high frequencies at which the 
AMFields effect is  observed may be used for 
application of high intensities required for 
deep tissue treatment without nerve or muscle 
stimulation [30]. 
6. Future applications of AMFields can include 
treatment for resistant and/or chronic 
infections or to  accelerate the treatment of 
common infections, such as tonsillitis, 
pharyngitis or similar, all by itself or  in 
parallel with antibiotics [30]. 
 
 
      CONCLUSION: 
 
 Alternating electric fields of intermediate frequencies 
when applied using non invasive electrically insulated 
electrodes have been reported to be beneficial in 
destroying some cancer cell lines and also have been 
found to have antimicrobial effects.  
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